Page last updated: 2024-08-24

prulifloxacin and Recrudescence

prulifloxacin has been researched along with Recrudescence in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bini, V; Costantini, E; Di Biase, M; Frumenzio, E; Giovannozzi, S; Maglia, D; Salvini, E1
Bini, V; Cicalese, A; Costantini, E; Filocamo, MT; Lazzeri, M; Li Marzi, V; Salvini, E; Zucchi, A1
Busetto, GM; De Berardinis, E; De Cobelli, O; Del Giudice, F; Ferro, M; Gentile, V; Giovannone, R; Matei, DV; Tricarico, S1
Blasi, F; Bonizzoni, E; Campanini, M; Casali, A; Colagrande, P; Giusti, M; Gussoni, G; Iori, I; Mazzone, A; Politi, C; Sgambato, F; Valerio, A1
Bartoletti, R; Boddi, V; Cai, T; Mazzoli, S; Mondaini, N; Nesi, G1

Trials

4 trial(s) available for prulifloxacin and Recrudescence

ArticleYear
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.
    International urogynecology journal, 2014, Volume: 25, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Dioxolanes; Female; Fluoroquinolones; Fosfomycin; Humans; Middle Aged; Piperazines; Recurrence; Treatment Outcome; Urinary Tract Infections

2014
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
    BMC urology, 2014, Jul-19, Volume: 14

    Topics: Adult; Anti-Bacterial Agents; Arbutin; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Dietary Supplements; Dioxolanes; Drug Administration Schedule; Fluoroquinolones; Humans; Lactobacillus; Male; Middle Aged; Piperazines; Plant Extracts; Prostatitis; Recurrence; Serenoa; Young Adult

2014
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics.
    COPD, 2016, Volume: 13, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dioxolanes; Disease Progression; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Piperazines; Pulmonary Disease, Chronic Obstructive; Recurrence; Retreatment; Single-Blind Method; Symptom Assessment; Symptom Flare Up; Treatment Failure

2016
14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:5

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Cystitis; Dioxolanes; Female; Fluoroquinolones; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Quality of Life; Recurrence; Treatment Outcome; Urinary Tract Infections; Urine; Vagina; Young Adult

2009

Other Studies

1 other study(ies) available for prulifloxacin and Recrudescence

ArticleYear
Role of phytotherapy associated with antibiotic prophylaxis in female patients with recurrent urinary tract infections.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2013, Dec-31, Volume: 85, Issue:4

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Combined Modality Therapy; Dioxolanes; Female; Fluoroquinolones; Fosfomycin; Humans; Middle Aged; Phytotherapy; Piperazines; Recurrence; Retrospective Studies; Urinary Tract Infections

2013